PMID: 3769771Oct 1, 1986Paper

Acute interstitial nephritis associated with intermittent rifampin use

Drug Intelligence & Clinical Pharmacy
M D Katz, E Lor

Abstract

Rifampin is a widely used antimicrobial agent, most commonly administered in the treatment of tuberculosis. Since its introduction in the late 1960s, rifampin has become a standard agent in the treatment of tuberculosis, especially with the acceptance of short-course chemotherapy in the U.S. Rifampin also is being used with increasing frequency in the treatment of nontuberculous infections, especially serious staphylococcal infections. While rifampin usually is well tolerated in most patients, adverse effects, including serious forms of toxicity, have been reported. Some of these adverse effects include liver toxicity and various immunologic reactions such as skin rashes, eosinophilia, and interstitial nephritis. This report documents a case of acute interstitial nephritis, most likely secondary to intermittent rifampin administration.

References

Mar 1, 1977·The Journal of Antimicrobial Chemotherapy·D J Girling
Aug 7, 1971·British Medical Journal·G PooleS Worlledge
Jul 1, 1983·Reviews of Infectious Diseases·J Grosset, S Leventis
Mar 1, 1984·The New England Journal of Medicine·D M Clive, J S Stoff
Jun 1, 1980·Southern Medical Journal·W Y QunibiG Eknoyan

❮ Previous
Next ❯

Citations

Mar 23, 2010·Revista Do Instituto De Medicina Tropical De São Paulo·Olufunsho AwodeleHerbert A B Coker
Dec 3, 1998·Renal Failure·E Alexopoulos
Sep 1, 1995·Pharmacotherapy·E BlackwellM Smythe
Jan 25, 2017·The Journal of Pharmacology and Experimental Therapeutics·Kristine O Vasquez, Jeffrey D Peterson
Aug 8, 2021·International Journal of Molecular Sciences·Maroun Bou ZerdanHazem I Assi

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Related Papers

Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
S YanS Lin
DICP : the Annals of Pharmacotherapy
E A Forrence, M P Goldman
Australian and New Zealand Journal of Medicine
W J SiebertP E Aylward
© 2021 Meta ULC. All rights reserved